211 related articles for article (PubMed ID: 8205703)
1. Modulation of procainamide's effect on cardiac conduction in dogs by extracellular potassium concentration. A quantitative analysis.
Villemaire C; Nattel S
Circulation; 1994 Jun; 89(6):2870-8. PubMed ID: 8205703
[TBL] [Abstract][Full Text] [Related]
2. A quantitative analysis of use-dependent ventricular conduction slowing by procainamide in anesthetized dogs.
Villemaire C; Savard P; Talajic M; Nattel S
Circulation; 1992 Jun; 85(6):2255-66. PubMed ID: 1317275
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of procainamide-induced rate-dependent conduction slowing by elevated myocardial extracellular potassium concentration in vivo.
Cascio WE; Foster JR; Buchanan JW; Johnson TA; Gettes LS
Circulation; 1987 Dec; 76(6):1380-7. PubMed ID: 3677360
[TBL] [Abstract][Full Text] [Related]
4. Rate-dependent changes in intraventricular conduction produced by procainamide in anesthetized dogs. A quantitative analysis based on the relation between phase 0 inward current and conduction velocity.
Nattel S; Jing W
Circ Res; 1989 Dec; 65(6):1485-98. PubMed ID: 2582585
[TBL] [Abstract][Full Text] [Related]
5. Modulation of procainamide's effect on conduction by cellular uncoupling in perfused rabbit hearts.
Spear JF; Hook BG; Josephson ME; Moore EN
J Cardiovasc Electrophysiol; 1997 Feb; 8(2):199-214. PubMed ID: 9048250
[TBL] [Abstract][Full Text] [Related]
6. The effects of procainamide on conduction in anisotropic canine ventricular myocardium.
Kadish AH; Spear JF; Levine JH; Moore EN
Circulation; 1986 Sep; 74(3):616-25. PubMed ID: 3742759
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of procainamide, lidocaine and acetylstrophanthidin on body surface potentials and epicardial conduction in dogs with chronic myocardial infarction.
de Langen CD; Hanich RF; Michelson EL; Kadish AH; Levine JH; Balke CW; Spear JF; Moore EN
J Am Coll Cardiol; 1988 Feb; 11(2):403-13. PubMed ID: 3339181
[TBL] [Abstract][Full Text] [Related]
8. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit.
Stambler BS; Wood MA; Ellenbogen KA
J Am Coll Cardiol; 1996 Feb; 27(2):453-61. PubMed ID: 8557920
[TBL] [Abstract][Full Text] [Related]
10. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.
Echt DS; Black JN; Barbey JT; Coxe DR; Cato E
Circulation; 1989 May; 79(5):1106-17. PubMed ID: 2469545
[TBL] [Abstract][Full Text] [Related]
12. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
Kirchhof PF; Fabritz CL; Franz MR
Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478
[TBL] [Abstract][Full Text] [Related]
13. Enhancement by hyponatremia and hyperkalemia of ventricular conduction and rhythm disorders caused by bupivacaine.
Timour Q; Freysz M; Mazze R; Couzon P; Bertix L; Faucon G
Anesthesiology; 1990 Jun; 72(6):1051-6. PubMed ID: 2350020
[TBL] [Abstract][Full Text] [Related]
14. Dual rate-dependent cardiac electrophysiologic effects of haloperidol: slowing of intraventricular conduction and lengthening of repolarization.
Mörtl D; Agneter E; Krivanek P; Koppatz K; Todt H
J Cardiovasc Pharmacol; 2003 Jun; 41(6):870-9. PubMed ID: 12775964
[TBL] [Abstract][Full Text] [Related]
15. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of verapamil and procainamide on rate-dependent bundle branch block: pharmacologic evidence for the role of depressed sodium channel responses.
Chiale PA; Pastori JD; Sánchez RA; Elizari MV; Rosenbaum MB
J Am Coll Cardiol; 1990 Mar; 15(3):633-9. PubMed ID: 2154512
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the rate-dependent effects of ethmozine on conduction, in vivo, and on the sodium current, in vitro, in the newborn heart.
Liu W; Clarkson CW; Yamasaki S; Chang C; Stolfi A; Pickoff AS
J Pharmacol Exp Ther; 1992 Nov; 263(2):608-16. PubMed ID: 1331407
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.
Ranger S; Talajic M; Lemery R; Roy D; Villemaire C; Nattel S
Circulation; 1991 Jun; 83(6):1987-94. PubMed ID: 2040051
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of rate-dependent slowing of intraventricular conduction by the class Ib antiarrhythmic agent tocainide in vivo.
Todt H; Zojer N; Raberger G
Br J Pharmacol; 1993 Sep; 110(1):145-50. PubMed ID: 8220875
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of verapamil and procainamide on intraventricular conduction and reentry within the His-Purkinje system in man.
Reddy CP; Orr CM; McAllister RG
Acta Cardiol; 1982; 37(4):269-86. PubMed ID: 6981905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
